chr11-33700622-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001166692.2(C11orf91):āc.119A>Gā(p.Asn40Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,475,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001166692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C11orf91 | NM_001166692.2 | c.119A>G | p.Asn40Ser | missense_variant | 1/2 | ENST00000379011.5 | NP_001160164.1 | |
C11orf91 | XM_017017053.2 | c.119A>G | p.Asn40Ser | missense_variant | 2/3 | XP_016872542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C11orf91 | ENST00000379011.5 | c.119A>G | p.Asn40Ser | missense_variant | 1/2 | 1 | NM_001166692.2 | ENSP00000368296 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151890Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000806 AC: 7AN: 86844Hom.: 0 AF XY: 0.000102 AC XY: 5AN XY: 49048
GnomAD4 exome AF: 0.000137 AC: 182AN: 1323678Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 105AN XY: 652158
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151890Hom.: 0 Cov.: 33 AF XY: 0.0000809 AC XY: 6AN XY: 74180
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.119A>G (p.N40S) alteration is located in exon 1 (coding exon 1) of the C11orf91 gene. This alteration results from a A to G substitution at nucleotide position 119, causing the asparagine (N) at amino acid position 40 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at